# Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity

> **NCT06418074** · NA · COMPLETED · sponsor: **Gødstrup Hospital** · enrollment: 20 (actual)

## Conditions studied

- Ketosis
- Essential Hypertension

## Interventions

- **DIETARY_SUPPLEMENT:** Ketone Monoester (KE4)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06418074
- **Lead sponsor:** Gødstrup Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-11
- **Primary completion:** 2025-06-19
- **Final completion:** 2025-06-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06418074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06418074, "Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06418074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
